Cited by 112Advanced Drug Delivery SystemsNanoparticle-Based Drug DeliveryInhalation and Respiratory Drug Delivery

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route

Shah, Brijesh, Khunt, Dignesh, Misra, Manju, Padh, Harish·2016·International Journal of Biological Macromolecules

DOI 10.1016/j.ijbiomac.2016.04.076

Open this paper in CoChat — free account

Abstract

The objective of the present investigation was to optimize and develop quetiapine fumarate (QF) loaded chitosan nanoparticles (QF-NP) by ionic gelation method using Box-Behnken design. Three independent variables viz., X1-Concentration of chitosan, X2-Concentration of sodium tripolyphosphate and X3-Volume of sodium tripolyphosphate were taken to investigate their effect on dependent variables (Y1-Size, Y2-PDI and Y3-%EE). Optimized formula of QF-NP was selected from the design space which was further evaluated for physicochemical, morphological, solid state characterization, nasal diffusion and in-vivo distribution for brain targeting following non-invasive intranasal administration. The average particle size, PDI, %EE and nasal diffusion were found to be 131.08±7.45nm, 0.252±0.064, 89.93±3.85% and 65.24±5.26% respectively. Neither toxicity nor structural damage on nasal mucosa was observed upon histopathological examination. Significantly higher brain/blood ratio and 2 folds higher nasal bioavailability in brain with QF-NP in comparison to drug solution following intranasal administration revealed preferential nose to brain transport bypassing blood-brain barrier and prolonged retention of QF at site of action suggesting superiority of chitosan as permeability enhancer. Overall, the above finding shows promising results in the area of developing non-invasive intranasal route as an alternative to oral route for brain delivery.

Integrity signals

Registry

Crossref · 10.1016/j.ijbiomac.2016.04.076

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Box-Behnken design: An alternative for the optimization of analytical methods
Ferreira, S. L. C., Bruns, R. E., Ferreira, H. S., Matos, G. D., David, J. M., Brandão, G. C., da Silva, E. G. P., Portugal, L. A., dos Reis, P. S., Souza, A. S., et al. (2007) · Analytica Chimica Acta · doi:10.1016/j.aca.2007.07.011 · Cited by 3,214
Intranasal delivery to the central nervous system: Mechanisms and experimental considerations
Dhuria, S. V., Hanson, L. R., & Frey, W. H. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21924 · Cited by 1,239
Nanoparticulate systems for brain delivery of drugs.
Kreuter, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00122-8 · Cited by 1,107
Nanoparticulate systems for brain delivery of drugs
Kreuter, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.015 · Cited by 965
Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique
Fan, W., Yan, W., Xu, Z., & Ni, H. (2011) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2011.09.042 · Cited by 930
Atypical antipsychotics: Mechanism of action
Seeman, P. (2002) · The Canadian Journal of Psychiatry · doi:10.1177/070674370204700106 · Cited by 899
Chitosan nanoparticle as protein delivery carrier—Systematic examination of fabrication conditions for efficient loading and release
Gan, Q., & Wang, T. (2007) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2007.04.009 · Cited by 712
Chitosan in nasal delivery systems for therapeutic drugs
Casettari, L., & Illum, L. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.003 · Cited by 448
Strategy for effective brain drug delivery
Alam, M. I., Beg, S., Samad, A., Baboota, S., Kohli, K., Ali, J., Ahuja, A., & Akbar, M. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.05.003 · Cited by 415
Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening
Yeh, T.-H., Hsu, L.-W., Tseng, M. T., Lee, P., Sonjae, K., Ho, Y., & Sung, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.056 · Cited by 381

Show all 38 references

Sorted by citations

Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors
Jeong, S., Jang, J.-H., & Lee, Y. (2022) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-022-00589-5 · Cited by 289
“The applied nanoformulations ranged from nanoparticles (Elnaggar et al. 2015; Eskandari et al. 2011; Hanafy et al. 2016; Meng et al. 2018; Salem et al. 2019; Seju et al. 2011; Shah et al. 2016; Zhang et al. 2014), to nanoemulsions (Abdou et al.”
Background
Nose-to-Brain Delivery
Wang, Z., Xiong, G., Tsang, W. C., Schätzlein, A. G., & Uchegbu, I. F. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.258152 · Cited by 247
“09% when dosed as chitosan–tripolyphosphate nanoparticles (Shah et al., 2016).”
Background
Nanosystems in nose-to-brain drug delivery: A review of non-clinical brain targeting studies
Pires, P. C., & Santos, A. O. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.047 · Cited by 228
Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier
Lee, D., & Minko, T. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122049 · Cited by 227
Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders
Islam, S. U., Shehzad, A., Ahmed, M. B., & Lee, Y. S. (2020) · Molecules · doi:10.3390/molecules25081929 · Cited by 193
“Compared to an intranasal solution, quetiapine chitosan nanoparticles enhanced the drug delivery to the brain by 34% [179].”
BackgroundInfluential
Nose to brain delivery of rotigotine loaded chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of Parkinson's disease
Bhattamisra, S. K., Tzeyung, A. S., Xi, L. W., Safian, N. H. B., Choudhury, H., Lim, W., Shahzad, N., Alhakamy, N. A., Anwer, M. K., Radhakrishnan, A. K., et al. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119148 · Cited by 172
Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations
Zorkina, Y., Abramova, O. V., Ushakova, V. M., Morozova, A. Y., Zubkov, E. A., Valikhov, M. P., Melnikov, P., Majouga, A. G., & Chekhonin, V. P. (2020) · Molecules · doi:10.3390/molecules25225294 · Cited by 166
The Potential of Chitosan in Nanomedicine: An Overview of the Cytotoxicity of Chitosan Based Nanoparticles
Frigaard, J. M., Jensen, J. L., Galtung, H. K., & Hiorth, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.880377 · Cited by 157
Polymeric nanocarriers for nose-to-brain drug delivery in neurodegenerative diseases and neurodevelopmental disorders
Awad, R., Avital, A., & Sosnik, A. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.07.003 · Cited by 150
RETRACTED: Fabrication, Optimization, and Evaluation of Rotigotine-Loaded Chitosan Nanoparticles for Nose-To-Brain Delivery
Tzeyung, A. S., Md, S., Bhattamisra, S. K., Madheswaran, T., Alhakamy, N. A., Aldawsari, H. M., & Radhakrishnan, A. K. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11010026 · Cited by 133
“This could be due to the presence of positively-charged chitosan which interacts with the negative surface of sialic acid residues in the cell membrane, this helping in the modulation of tight junction components on the mucosa, which will consequently enhance the paracellular transport and permeation across the nasal…”
BackgroundMethodInfluential
Retracted
An update on the role of nanovehicles in nose-to-brain drug delivery
Feng, Y., He, H., Li, F., Lü, Y., Qi, J., & Wu, W. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.005 · Cited by 127
Temozolomide loaded nano lipid based chitosan hydrogel for nose to brain delivery: Characterization, nasal absorption, histopathology and cell line study
Khan, A. S., Aqil, M., Imam, S. S., Ahad, A., Sultana, Y., Ali, A., & Khan, K. M. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.05.079 · Cited by 111
Chitosan Nanoparticles for Intranasal Drug Delivery
Omidian, H., Gill, E. J., Chowdhury, S. D., & Cubeddu, L. X. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16060746 · Cited by 98
Neuroprotective and Antioxidant Effect of Naringenin-Loaded Nanoparticles for Nose-to-Brain Delivery
Md, S., Alhakamy, N. A., Aldawsari, H. M., & Asfour, H. Z. (2019) · Brain Sciences · doi:10.3390/brainsci9100275 · Cited by 84
“This may be explained by more chitosan chains per volume at higher chitosan concentrations; this would lead to insufficient electrostatic repulsion, stronger intermolecular hydrogen bonding attraction, and decreased intermolecular distance resulting in the formation of larger particles with non-uniform particle size d…”
BackgroundInfluential
pH stimuli-responsive hydrogels from non-cellulosic biopolymers for drug delivery.
Vegad, U., Patel, M., Khunt, D., Zupančič, O., Chauhan, S., & Paudel, A. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1270364 · Cited by 85
“Apart from that, Chitosan shows strong mucoadhesive properties due to its cationic nature and interaction with net negatively charged intestinal mucus layer, enhancing its residence time in the colon and drug diffusion gradient, leading to increased absorption (Shah et al., 2016).”
Background
Formulation optimization, characterization, and evaluation of in vitro cytotoxic potential of curcumin loaded solid lipid nanoparticles for improved anticancer activity
Rompicharla, S. V. K., Bhatt, H., Shah, A., Komanduri, N., Vijayasarathi, D., Ghosh, B., & Biswas, S. (2017) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2017.08.009 · Cited by 75
“(Shah et al., 2016).”
Intranasal Delivery of Functionalized Polymeric Nanomaterials to the Brain
Zha, S., Wong, K., & All, A. H. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202102610 · Cited by 72
Cationic biopolymer functionalized nanoparticles encapsulating lutein to attenuate oxidative stress in effective treatment of Alzheimer’s disease: A non-invasive approach
Dhas, N. L., & Mehta, T. A. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119553 · Cited by 67
Nose-to-brain delivery of antipsychotics using nanotechnology: a review
Tan, M. S. A., Parekh, H. S., Pandey, P. M., Siskind, D. J., & Falconer, J. R. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1762563 · Cited by 68
Preparation, Characterization, In Vitro Release, and Antibacterial Activity of Oregano Essential Oil Chitosan Nanoparticles
Ma, Y., Liu, P., Ye, K., He, Y., Chen, S., Yuan, A., Chen, F., & Yang, W. (2022) · Foods · doi:10.3390/foods11233756 · Cited by 61
“The terms A, B, and C are independent variables, whereas (AB, AC, and BC) and (A2, B2, and C2) are interaction and quadratic effects, respectively [23].”
BackgroundInfluential
Formulation and In-vivo Pharmacokinetic Consideration of Intranasal Microemulsion and Mucoadhesive Microemulsion of Rivastigmine for Brain Targeting
Shah, B. M., Khunt, D., Misra, M., & Padh, H. (2018) · Pharmaceutical Research · doi:10.1007/s11095-017-2279-z · Cited by 58
“…AUC0–240, T1/2, brain targeting efficiency (DTE), direct transport percentage (DTP) and nasal bioavailability for each treatment group using pharmacokinetic software (PK Functions for Microsoft Excel, Pharsight Corporation, Mountain view, CA) as per the methods described by Shah et al., 2016 (6).”
BackgroundMethodResultInfluential
Chitosan Nanocarrier Entrapping Hydrophilic Drugs as Advanced Polymeric System for Dual Pharmaceutical and Cosmeceutical Application: A Comprehensive Analysis Using Box-Behnken Design
Abosabaa, S. A., ElMeshad, A. N., & Arafa, M. G. (2021) · Polymers · doi:10.3390/polym13050677 · Cited by 56
“Thus, the capacity of the CS to ionically interact with TPP ions was reduced resulting in a lower EE%, despite the larger size of formed nanoparticles [36].”
BackgroundMethod
CCRD based development of bromocriptine and glutathione nanoemulsion tailored ultrasonically for the combined anti-parkinson effect
Ashhar, M. U., Kumar, S., Ali, J., & Baboota, S. (2021) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2020.105035 · Cited by 55
Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies
Goel, H., Kalra, V., Verma, S. K., Dubey, S. K., & Tiwary, A. K. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.12.009 · Cited by 56
Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer’s disease in intracerebroventricular streptozotocin model for brain delivery
Zameer, S., Ali, J., Vohora, D., Najmi, A. K., & Akhtar, M. (2020) · Journal of drug targeting · doi:10.1080/1061186x.2020.1817041 · Cited by 51
“It has been acknowledged that the application of CS to confluent cell cultures leads to open the tight junctions between the cells transiently [48].”
Formulation and Evaluation of Neuroactive Drug Loaded Chitosan Nanoparticle for Nose to Brain Delivery: In-vitro Characterization and In-vivo Behavior Study
Qureshi, M., Aqil, M., Imam, S. S., Ahad, A., & Sultana, Y. (2018) · Current Drug Delivery · doi:10.2174/1567201815666181011121750 · Cited by 53
Intranasal delivery of chitosan decorated PLGA core /shell nanoparticles containing flavonoid to reduce oxidative stress in the treatment of Alzheimer's disease
Dhas, N. L., & Mehta, T. A. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.102242 · Cited by 49
Delivery of Antipsychotics with Nanoparticles
Sun, Y., Chen, K., Liu, F., & Lei, S. (2016) · Drug Development Research · doi:10.1002/ddr.21331 · Cited by 42
“In vivo studies in rats showed a prolonged peak concentration and a greater than 10-fold increase in bioavailability for QF. Shah et al. developed QF-loaded chitosan nanoparticles (QF-NP) for delivery [Shah et al., 2016].”
BackgroundMethod
Nanoscaled Dispersed Systems Used in Drug-Delivery Applications
Cheaburu-Yılmaz, C. N., Karasulu, H. Y., & Yılmaz, O. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813932-5.00013-3 · Cited by 44
Central Composite Optimization of Glycerosomes for the Enhanced Oral Bioavailability and Brain Delivery of Quetiapine Fumarate
Zaki, R. M., Alfadhel, M. M., Alossaimi, M. A., Elsawaf, L. A., Seshadri, V. D., Almurshedi, A. S., Yusif, R. M., & Said, M. (2022) · Pharmaceuticals · doi:10.3390/ph15080940 · Cited by 40
“QTF has a plasma half-life of 6 h, and as a result, it needs frequent dosing to maintain effective therapeutic concentration [12].”
Background
Role of Omega-3 Fatty Acids and Butter Oil in Targeting Delivery of Donepezil Hydrochloride Microemulsion to Brain via the Intranasal Route: a Comparative Study
Khunt, D., Shrivas, M., Polaka, S., Gondaliya, P., & Misra, M. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-019-1585-7 · Cited by 40
Derivation of composites of chitosan-nanoparticles from crustaceans source for nanomedicine: A mini review
Abere, D. V., Ojo, S. A., Paredes-Epinosa, M. B., & Hakami, A. (2022) · Biomedical Engineering Advances · doi:10.1016/j.bea.2022.100058 · Cited by 40
Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS
Sarma, A., & Das, M. K. (2020) · Molecular Biomedicine · doi:10.1186/s43556-020-00019-8 · Cited by 39
In-depth Mechanism, Challenges, and Opportunities of Delivering Therapeutics in Brain Using Intranasal Route
Ghosh, A., Majie, A., Karmakar, V., Chatterjee, K., Chakraborty, S., Pandey, M., Jain, N., Sarkar, S. R., Nair, A. B., & Gorain, B. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02810-0 · Cited by 40
Targeting neuroinflammation by intranasal delivery of nanoparticles in neurological diseases: a comprehensive review
Moradi, F., & Dashti, N. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-021-02196-x · Cited by 37
“Compared to an IN solution, quetiapine fumarate-loaded CT NPs increased 2 times brain bioavailability (Shah et al. 2016).”
Background
Nose-to-Brain Drug Delivery and Physico-Chemical Properties of Nanosystems: Analysis and Correlation Studies of Data from Scientific Literature
Bonaccorso, A., Ortis, A., Musumeci, T., Carbone, C., Hussain, M., Salvatore, V. D., Battiato, S., Pappalardo, F., & Pignatello, R. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s452316 · Cited by 35
Ursolic acid loaded intra nasal nano lipid vesicles for brain tumour: Formulation, optimization, in-vivo brain/plasma distribution study and histopathological assessment
Khan, K., Aqil, M., Imam, S. S., Ahad, A., Moolakkadath, T., Sultana, Y., & Mujeeb, M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.127 · Cited by 35
Nanoparticle Brain Delivery: A Guide to Verification Methods
Yokel, R. A. (2020) · Nanomedicine · doi:10.2217/nnm-2019-0169 · Cited by 36
Natural Polysaccharide Carriers in Brain Delivery: Challenge and Perspective
Curcio, M., Cirillo, G., Rouaen, J. R. C., Saletta, F., Nicoletta, F. P., Vittorio, O., & Iemma, F. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121183 · Cited by 35
“CH [95] NP (ion gelation) NB Schizophrenia QF GNM SD rats Enhanced permeation § Improved pharmacokinetics #”
BackgroundMethod
Amelioration of oxidative stress utilizing nanoemulsion loaded with bromocriptine and glutathione for the management of Parkinson's disease
Ashhar, M. U., Vyas, P., Vohora, D., Sahoo, P. K., Nigam, K., Dang, S., Ali, J., & Baboota, S. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121683 · Cited by 36
Unraveling the role of chitosan for nasal drug delivery systems: A review
Kaur, G., Goyal, J., Behera, P. K., Devi, S., Singh, S. K., Garg, V., & Mittal, N. (2023) · Carbohydrate Polymer Technologies and Applications · doi:10.1016/j.carpta.2023.100316 · Cited by 34
Formulation by Design (FbD) approach to develop Tenofovir Disoproxil Fumarate loaded Nanostructured Lipid Carriers (NLCs) for the aptness of nose to brain delivery
Sarma, A., & Das, M. K. (2019) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v9i2.2391 · Cited by 32
Nose-to-brain drug delivery
Alexander, A., Agrawal, M., Chougule, M. B., Saraf, S., & Saraf, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817778-5.00009-9 · Cited by 31
Product transfer from lab-scale to pilot-scale of quetiapine fumarate orodispersible films using quality by design approach
Bülbül, E. Ö., Mesut, B., Cevher, E., Öztaş, E., & Özsoy, Y. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.101358 · Cited by 30
Quality by design engineered, enhanced anticancer activity of temozolomide and resveratrol coloaded NLC and brain targeting via lactoferrin conjugation in treatment of glioblastoma
Mittal, S., Shah, S. Z., Yadav, H. N., Ali, J., Gupta, M. M., & Baboota, S. (2023) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2023.08.018 · Cited by 29
Advancement in the Nose-to-Brain Drug delivery of FDA-approved drugs for the better management of Depression and Psychiatric disorders
Upadhyay, R. K., Ghosh, P., & Desavathu, M. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124866 · Cited by 31
Chitosan nanoparticles for nasal drug delivery
Alghareeb, S., Ekenna, I. C., Asare‐Addo, K., Conway, B. R., & Adebisi, A. O. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106623 · Cited by 32
Formulation, design and strategies for efficient nanotechnology-based nasal delivery systems
de Barros, C. T., Portugal, I., Batain, F., Portella, D. L., Severino, P. B., Cardoso, J. C., Arcuri, P., Chaud, M. V., & Alves, T. (2022) · RPS Pharmacy and Pharmacology Reports · doi:10.1093/rpsppr/rqac003 · Cited by 29
Comparative evaluation of intranasally delivered quetiapine loaded mucoadhesive microemulsion and polymeric nanoparticles for brain targeting: pharmacokinetic and gamma scintigraphy studies
Shah, B. M., Khunt, D., & Misra, M. (2021) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-020-00156-5 · Cited by 29
“have been published by our group [17]; hence, only optimized procedure is discussed in this article.”
BackgroundMethodInfluential
Microemulsion as a promising carrier for nose to brain delivery: journey since last decade
Shah, B. M. (2021) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-021-00528-w · Cited by 26
Polymeric nanoparticles for efficient nose-to-brain delivery
Bolon, M., Fieux, M., Monge, C., & Richard, S. (2025) · Nanoscale · doi:10.1039/d5nr00870k · Cited by 26
Drug Delivery Systems and Strategies to Overcome the Barriers of Brain
Garg, Y., Kapoor, D. N., Sharma, A. K., & Bhatia, A. (2021) · Current Pharmaceutical Design · doi:10.2174/1381612828666211222163025 · Cited by 21
The state of the art of nanopsychiatry for schizophrenia diagnostics and treatment
Radaic, A., & Martins‐de‐Souza, D. (2020) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2020.102222 · Cited by 21
Optimization and Appraisal of Chitosan-Grafted PLGA Nanoparticles for Boosting Pharmacokinetic and Pharmacodynamic Effect of Duloxetine HCl Using Box-Benkhen Design
Salem, H. F., Ali, A. A., Rabea, Y. K., El‐Ela, F. I. A., & Khallaf, R. A. (2022) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2022.08.034 · Cited by 17
To see or not to see: In vivo nanocarrier detection methods in the brain and their challenges
Wehn, A. C., Krestel, E., Harapan, B. N., Klymchenko, A. S., Plesnila, N., & Khalin, I. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.05.044 · Cited by 14
Promising brain biodistribution of insulin via intranasal dry powder for nose-to-brain delivery
Muntu, C. M., Avanti, C., Hayun, H., & Surini, S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33657 · Cited by 15
“The IDP formulation irritation test with goat nasal mucosa was used to observe the impact of the sample on the morphology of the mucosa [25,26].”
Method
Chitin and Chitosan in Drug Delivery
Parhi, R. (2019) · Sustainable agriculture reviews · doi:10.1007/978-3-030-16581-9_6 · Cited by 15
Quality by design and formulation optimization using statistical tools for safe and efficient bioactive loading
Pradhan, M., Parihar, A. K., Singh, D., & Singh, M. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819666-3.00019-5 · Cited by 14
Encapsulation of the Natural Product Tyrosol in Carbohydrate Nanosystems and Study of Their Binding with ctDNA
Pontillo, A. R. N., Konstanteli, E., Bairaktari, M., & Detsi, A. (2020) · Polymers · doi:10.3390/polym13010087 · Cited by 14
“[31], prepared CS nanoparticles loaded with quetiapine fumarate sized between 140 and 487 nm.”
Method
Role of nano-lipid formulation of CARP-1 mimetic, CFM-4.17 to improve systemic exposure and response in osimertinib resistant non-small cell lung cancer
Kommineni, N., Nottingham, E., Bagde, A., Patel, N., Rishi, A. K., Dev, S. R. S., & Singh, M. S. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.11.007 · Cited by 14
“error and ‘3’ refers to the number of the independent variables used [38].”
Background
Intranasal drug delivery: Pathways, challenges, and advancements in CNS targeting
Al‐Hajaj, N., Khalil, R., & Husseini, G. A. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106825 · Cited by 12
Nose to brain delivery of insulin loaded in PLGA and chitosan-coated PLGA nanoparticles: A promising approach for Alzheimer's disease therapy
Kouhjani, M., Jaafari, M. R., Saberi, A., Gholami, L., & Tafaghodi, M. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106857 · Cited by 13
RETRACTED: Transferrin-Conjugated Chitosan Nanoparticles for Direct Nose-to-Brain Delivery of Ziprasidone: Pharmacokinetic and Pharmacodynamic Evaluation
Ponduri, T. K., Guntupalli, C., Jeganathan, B., Malothu, N., & Kowtharapu, S. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00863 · Cited by 11
Retracted
Intranasal delivery of chitosan-based nanoparticles as an innovative way for management of neurodegenerative disorders: A comprehensive review of advanced strategies for CNS targeting
Ibrahim, R. M., Teaima, M. H. M., El-Nabarawi, M. A., & Badawi, N. M. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105885 · Cited by 12
Nose-to-Brain Delivery of Chitosan-Grafted Leciplexes for Promoting the Bioavailability and Antidepressant Efficacy of Mirtazapine: In Vitro Assessment and Animal Studies
Sisi, A. M. E., Eissa, E. M., Hassan, A. H. E., Bekhet, M. A., El‐Ela, F. I. A., Roh, E. J., Kharshoum, R. M., & Ali, A. A. (2025) · Pharmaceuticals · doi:10.3390/ph18010046 · Cited by 10
“(2) Surfactants in the nanosystem operate as penetration enhancers by lowering interfacial tension across the mucosal membrane [48].”
A comprehensive insight of innovations and recent advancements in nanocarriers for nose-to-brain drug targeting
Mubarak, N., Waqar, M. A., Khan, A. M., Asif, Z., Alvi, A. S., Virk, A. A., & Amir, S. (2025) · Designed Monomers & Polymers · doi:10.1080/15685551.2025.2464132 · Cited by 10
Quality-by-Design Approach Development, Characterization, and In Vitro Release Mechanism Elucidation of Nanostructured Lipid Carriers for Quetiapine Fumarate Oral Delivery
Ayed, O. B. H., Lassoued, M. A., & Sfar, S. (2021) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-021-09567-0 · Cited by 9
Effect of phosphatidylcholine in bentonite-quetiapine complex on enhancing drug release and oral bioavailability
Baek, M., Kim, G.-H., Park, J.-H., Kim, J., Kang, I.-M., Lee, J. I., & Kim, D. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122347 · Cited by 11
Modeling of drug release from a bioresorbable polymer matrix system
Yasir, M., Puri, D., Arumugam, M., Gobena, W. G., Wondabo, M. H., Roshan, S., & Noorulla, K. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18915-9.00040-9 · Cited by 9
Formulation Optimization of Gastro-Retention Tablets of Paeonol and Efficacy in Treatment of Experimental Gastric Ulcer
Zhang, X., Zhang, Y., Han, H., Yang, J., Xu, B., Wang, B., & Zhang, T. (2017) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c16-00993 · Cited by 9
Preparation of konjac glucomannan/casein blending gels optimized by response surface methodology and assessment of the effects of high‐pressure processing on their gel properties and structure
Zhang, F., Fan, Q. H., Li, H., Chen, H., & Zheng, J. (2018) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.8937 · Cited by 8
Meta-Analysis: A Convenient Tool for the Choice of Nose-to-Brain Nanocarriers
Hathout, R. M., & El-Marakby, E. M. (2022) · Bioengineering · doi:10.3390/bioengineering9110647 · Cited by 8
Advances of nanoparticles in transmucosal drug delivery
Zhang, L., Yang, C., Song, Y., Sheng, T., Li, J., Yu, J., Wu, X., & Ye, X. (2023) · Nano Research · doi:10.1007/s12274-023-6188-7 · Cited by 8
Applications of innovative technologies to the delivery of antipsychotics
Bergonzi, M. C., Bilia, A. R., & Landucci, E. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.09.019 · Cited by 8
Design of quetiapine fumarate loaded polyethylene glycol decorated graphene oxide nanosheets: In vitro-ex vivo characterization
Patil, G. S., Nangare, S., Patil, D. A., Borhade, D. D., & Patil, G. B. (2024) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2024.04.009 · Cited by 7
Polymeric Nanocarrier-Based Drug Formulations for Enhancing Nose-to-Brain Delivery
Naki, T., Peter, S., & Alven, S. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17101242 · Cited by 8
“The polymers that are suitable for the preparation of nanoparticles with a positively charged surface for nasal application are chitosan and its derivatives due to the occurrence of positive charges under the physiological conditions of the nasal environment [120–122].”
Precise Fabrication of Ocular Inserts Using an Innovative Laser-Driven CaliCut Technology: In Vitro and in Vivo Evaluation
Rana, D., Beladiya, J., Sheth, D. B., Salave, S., Sharma, A. K., Jindal, A. B., Patel, R., & Benival, D. M. (2023) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2023.12.015 · Cited by 7
Polysaccharide-based platforms for nasal delivery: design, features, and perspectives
Elmowafy, E. M., & Soliman, M. E. (2023) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-023-00626-x · Cited by 7
Nose to brain delivery for the treatment of Alzheimer's disease
Khunt, D., Salave, S., Rana, D., Benival, D. M., Gayakvad, B., & Prajapati, B. G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13205-6.00001-7 · Cited by 6
Applications of Polymeric Nanoparticle in Nose to Brain Drug Delivery
Sunena, S., Kumar, S., Sulekha, S., Tomar, D., Kumar, D., & Kishore, V. (2023) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2023.00988 · Cited by 6
In vitro characterization of statistically optimized quetiapine-loaded self-nanoemulsified systems with quality by design
Katamreddy, J. D., Yalavarthi, P. R., Rao, D. S., Teja, S. S., & Battu, S. (2018) · International Journal of Pharmaceutical Investigation · doi:10.4103/jphi.jphi_9_18 · Cited by 6
“Systemic drug delivery in schizophrenia is a major confront due to the presence of hindrances like, blood–brain barrier and P-glycoprotein, which forbid the entry of drugs into the brain.[1] Colloidal drug transporters resembling micelles, emulsions, liposomes, and nanoparticles have been largely accounted for brain d…”
Background
IMPACT OF LIGAND CONJUGATION OF PHYSICOCHEMICAL ATTRIBUTES OF POLYMERIC NANOPARTICLES OF ATYPICAL ANTIPSYCHOTIC DRUG FOR NOSE-TO-BRAIN DELIVERY
Ponduri, T. K., Guntupalli, C., Jeganathan, B., & Malothu, N. (2024) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2024v16i6.52003 · Cited by 5
“These findings align with the results obtained by Shah et al, who investigated the safety of Quetiapine NPs following nasal administration [25].”
Transferrin-Functionalized Chitosan Nanoparticles Enable Intranasal Brain Delivery of Cariprazine with Enhanced Neuropharmacological Efficacy
Ponduri, T. K., Guntupalli, C., Jeganathan, B., & Malothu, N. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00718 · Cited by 4
Advances in polysaccharide-based formulations for intranasal drug delivery: A review
Abubakar, B. D., Rosdan, B. S. M., Mohtar, N., & Nurul, A. A. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106266 · Cited by 4
The interplay of oxidative stress, apoptotic signaling, and impaired mitochondrial function in the pyrethroid-induced cardiac injury: Alleviative role of curcumin-loaded chitosan nanoparticle
Alhegaili, A. S., Bafail, D. A., Bawahab, A. A., Alsubaie, N., Abd‐Elhakim, Y. M., Mohamed, A. A.-R., Khamis, T., Khalifa, N. E., Elhamouly, M., Dahran, N. A., et al. (2024) · Food and Chemical Toxicology · doi:10.1016/j.fct.2024.115095 · Cited by 4
Nanotechnological advances in direct nose-to-brain drug delivery for neurodegenerative disorders and other neuroailments
Shukla, R., Kumar, A., & Flora, S. J. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822522-6.00005-9 · Cited by 5
Intranasal Delivery of Leuprolide Acetate Chitosan Nanoparticles for Treatment of Alzheimer’s Disease
Pandya, T., & Dharamsi, A. T. (2023) · Drug Delivery Letters · doi:10.2174/2210303113666230120124831 · Cited by 4
Exploiting itraconazole-loaded nanomixed micelles in coated capsules as efficient colon-targeted delivery system for improved antifungal and potential anticancer efficacy
Adel, S., Fahmy, R. H., Elsayed, I., Mohamed, M. I., & Ibrahim, R. R. (2023) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2023.2195486 · Cited by 4
“(Version 10.0.0, Stat-Ease Inc., Minneapolis, USA) (Shah et al. 2016; Goo et al. 2021).”
Influential
Carotenoid containing cationic nanoparticles for effective therapy for suppressing oxidative stress: An intranasal approach
Dhas, N. L., Garkal, A., Kudarha, R. R., Hebbar, S., Mutalik, S., & Mehta, T. A. (2023) · OpenNano · doi:10.1016/j.onano.2023.100172 · Cited by 4
Optimization of the silica‐gel adsorption technique for the extraction of phytosterol glycosides from soybean lecithin powder using response surface methodology and artificial neural network models
Kang, J., & Cao, D. (2020) · Journal of Food Science · doi:10.1111/1750-3841.15183 · Cited by 4
Optimization and Fabrication of Curcumin Loaded Solid Lipid Nanoparticles Using Box-Behnken Design for Nasal Delivery
Bhatt, S., Sharma, S., Sharma, J. B., & Kumar, M. (2022) · Nanoscience & Nanotechnology-Asia · doi:10.2174/2210681213666221103151333 · Cited by 3
Self‐assembled nanoparticles based on pullulan‐ g ‐poly( Z‐L ‐lysine) for controlled drug delivery: Synthesis, characterization and preliminary studies on the encapsulation of indomethacin
Vieira, T. A., Matos, L., de Carvalho, L. T., Alves, G. M., Lacerda, T. M., & Medeiros, S. F. (2024) · Journal of Applied Polymer Science · doi:10.1002/app.55632 · Cited by 3
Design, development, and evaluation of magnetic nanoparticles and docetaxel-loaded nanosystem for brain targeting
Gandhi, H., Kumar, D., Ghosh, S., Basu, B., & Kapoor, D. N. (2025) · Therapeutic Delivery · doi:10.1080/20415990.2025.2541573 · Cited by 2
Optimization of the Redox-Sensitive Doxorubicin-Loaded Chitosan-Based Nanoparticles by Box–Behnken Experimental Design
Babaei, M., Kashanian, S., & Salemi, Z. (2026) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-026-03517-1 · Cited by 2
An Emerging Prospective of Antipsychotics for Treating Neurodegenerative Disorders
Kumar, B., Sahoo, A., Singhal, M., Varshney, G., Halder, T., & Bali, V. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128344910241211112452 · Cited by 2
Biomedical Applications of Modified Chitosan Nanoparticles
Zia, K. M. (2025) · Smart nanomaterials technology · doi:10.1007/978-981-96-2629-8_7 · Cited by 2
Current advancements in nasopulmonary drug delivery systems
Ibrahim, A., Aziz, O. A. A., Dena, A. S. A., & El-sherbiny, I. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91668-4.00027-7 · Cited by 2
Harnessing Nanocarriers to Improve Psychiatric Treatment: Progress, Limitations, and Future Directions
Ge, X., Zhao, L., Xing, X., Hao, Y., Zhang, Z., & Sun, G. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s600278 · Cited by 1
Brain-targeted intranasal aripiprazole via modified chitosan nanoparticles: controlled release, pharmacokinetics, and pharmacodynamics
Ibrahim, R. M., Teaima, M. H. M., El-Nabarawi, M. A., & Badawi, N. M. (2026) · Drug Delivery and Translational Research · doi:10.1007/s13346-026-02193-8 · Cited by 1
NOSE TO BRAIN DELIVERY: ROLE OF VIRAL AND NON-VIRAL VECTORS FOR NEUROLOGICAL DISORDER
Musale, S., & Giram, P. S. (2021) · INDIAN DRUGS · doi:10.53879/id.58.05.12489 · Cited by 1

Authors: Shah, B., Khunt, D., Misra, M., & Padh, H.
Affiliations: B. V. Patel Pharmaceutical Education and Research Development Centre (IN)
National Institute of Pharmaceutical Education and Research - Ahmedabad (IN)
Sardar Patel University (IN)
Corresponding author: Misra, Manju
ORCID: Shah, Brijesh
Khunt, Dignesh
Misra, Manju
Padh, Harish
Venue: International Journal of Biological Macromolecules
Publisher: Elsevier BV
Published: 2016-08
Volume: 89
Pages: 206-218
ISSN: 0141-8130 (ISSN-L)
DOI: 10.1016/j.ijbiomac.2016.04.076
OpenAlex: W2381160200
Cited by: 112
References: 38
Citations by year: 2026: 12 · 2025: 11 · 2024: 15 · 2023: 13 · 2022: 14 · 2021: 11 · 2020: 18 · 2019: 7 · 2018: 7 · 2017: 3 · 2016: 1
FWCI: 3.42
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
doi.org/10.15223/policy-017 (stm-asf)
doi.org/10.15223/policy-037 (stm-asf)
doi.org/10.15223/policy-012 (stm-asf)
doi.org/10.15223/policy-029 (stm-asf)
doi.org/10.15223/policy-004 (stm-asf)
Locations: International Journal of Biological Macromolecules (publishedVersion)
PubMed (publishedVersion)
Funders: Lady Tata Memorial Trust
Department of Science and Technology, Government of Kerala
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
Keywords: quetiapine, chitosan nanoparticles, intranasal drug delivery, brain targeting, ionic gelation, Box-Behnken design, sodium tripolyphosphate, brain-to-blood ratio, blood-brain barrier bypass, particle size and polydispersity, encapsulation efficiency
MeSH terms: Quetiapine Fumarate, Administration, Intranasal, Animals, Biological Availability, Brain, Drug Carriers, Drug Compounding, Factor Analysis, Statistical, Goats, Nasal Mucosa, Particle Size, Permeability, Polyphosphates, Tissue Distribution, Antipsychotic Agents, Rats, Sprague-Dawley, Area Under Curve, Tissue Culture Techniques, Chitosan, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks